Mosunetuzumab for CLL MRD Clearance

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Leukemia · Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Brigham & Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Inhye Ahn, MD) · DFCILymphomaResearchNurses@partners.org · 877-DF-TRIAL
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Inhye Ahn, MD) · DFCILymphomaResearchNurses@partners.org · 877-DF-TRIAL

Study leads

Inhye Ahn, MD
Principal Investigator
Dana-Farber Cancer Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

Recurrent Chronic Lymphocytic Leukemia · Recurrent Small Lymphocytic Lymphoma · Refractory Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL)

Abroad (travel likely)RecruitingPHASE2

Concord, Australia · Kogarah, Australia

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

Acute Myelogenous Leukemia · Acute Lymphatic Leukemia · Chronic Myelogenous Leukemia

Abroad (travel likely)RecruitingPHASE2

Cleveland, United States

Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families

Leukemia · Non Hodgkin Lymphoma

Abroad (travel likely)Recruiting

Aurora, United States